Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-04-16 | Revance Therapeutics, Inc. | Jordan Erica
(Chief Commercial Officer) |
S | Common Stock | D | 2392 | $3.80 - $3.80 | $9,096 |
2024-03-18 | Revance Therapeutics, Inc. | Sjuts Dustin S
(President) |
S | Common Stock | D | 9211 | $5.04 - $5.04 | $46,446 |
2024-03-15 | Revance Therapeutics, Inc. | Sjuts Dustin S
(President) |
F | Common Stock | D | 2967 | $5.30 - $5.30 | $15,739 |
2024-03-18 | Revance Therapeutics, Inc. | Moxie Dwight
(CLO & GC) |
S | Common Stock | D | 8125 | $5.04 - $5.04 | $40,971 |
2024-03-15 | Revance Therapeutics, Inc. | Moxie Dwight
(CLO & GC) |
F | Common Stock | D | 3269 | $5.30 - $5.30 | $17,342 |
2024-03-18 | Revance Therapeutics, Inc. | Schilke Tobin
(CFO) |
S | Common Stock | D | 9361 | $5.04 - $5.04 | $47,203 |
2024-03-15 | Revance Therapeutics, Inc. | Schilke Tobin
(CFO) |
F | Common Stock | D | 3822 | $5.30 - $5.30 | $20,275 |
2024-03-15 | Revance Therapeutics, Inc. | Foley Mark J
(CEO) |
F | Common Stock | D | 20533 | $5.30 - $5.30 | $108,927 |
2024-02-29 | Revance Therapeutics, Inc. | Schilke Tobin
(CFO) |
A | Common Stock | A | 17447 | $0.00 - $0.00 | $0 |
2024-01-31 | Revance Therapeutics, Inc. | Moxie Dwight
(SVP, GC & Secretary) |
A | Common Stock | A | 90000 | $0.00 - $0.00 | $0 |
2024-01-31 | Revance Therapeutics, Inc. | Schilke Tobin
(CFO) |
A | Common Stock | A | 96667 | $0.00 - $0.00 | $0 |
2023-12-31 | Revance Therapeutics, Inc. | Sjuts Dustin S
(President) |
A | Common Stock | A | 264 | $7.47 - $7.47 | $1,972 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |